Diabetic macular edema (DME) is an eye condition that can lead to vision loss in people with diabetes. It occurs as a result of diabetic retinopathy — damaged blood vessels in the eyes due to elevated ...

The eye is made up of several different parts. One of these parts is the retina, which is home to special nerve cells that respond to light. The macula is part of that network and is located in the ...

A growing body of real-world data shows efficacy of injectable treatments for pseudophakic cystoid macular edema, but evidence from well-designed large studies is lacking, according to a systematic ...

Feb. 6, 2025 — The FDA has approved a new implantable treatment for adults with diabetic macular edema (DME) after studies showed that it could help maintain vision with as few as two treatments per ...

Please provide your email address to receive an email when new articles are posted on . One specialist highlighted cases in which systemic treatments, such as corticosteroids, are better. Another ...

B lack adults living with diabetes — either type 1 or type 2 — are especially prone to developing complications. This includes diabetic macular edema (DME), a complication in which swelling inside the ...

If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated ...

Vision tools, rehabilitation, and lifestyle changes can all help improve the experience of living with diabetic macular edema (DME). Macular edema is a condition that involves swelling in the eye that ...

Edema is the accumulation of excess fluid in body tissues, causing noticeable swelling, commonly in the feet, ankles, and legs. It affects older adults, pregnant women, and those with heart, kidney, ...

JUPITER, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (LGND) today announced that its partner SQ Innovation Inc. has received approval from the U.S. Food and Drug ...